R
Rafael Molina
Researcher at University of Granada
Publications - 398
Citations - 11970
Rafael Molina is an academic researcher from University of Granada. The author has contributed to research in topics: Image restoration & Iterative reconstruction. The author has an hindex of 52, co-authored 381 publications receiving 10765 citations. Previous affiliations of Rafael Molina include Intel & Northwestern University.
Papers
More filters
Journal ArticleDOI
Pro-Gastrin-Releasing Peptide in Patients with Benign and Malignant Diseases
TL;DR: In this article, the specificity and sensitivity of ProGastrin-releasing peptide (ProGRP) was evaluated in 37 healthy subjects, 197 patients with benign diseases and 310 patients with malignant diseases of different origins.
Journal ArticleDOI
High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Oscar Vidal,Jean-Philippe Metges,I. Elizalde,Mauro Valentini,A. Volant,Rafael Molina,Antoni Castells,Miguel Pera +7 more
TL;DR: The prognostic value of preoperative serum VEGF and serum uPA levels was evaluated in patients undergoing potentially curative (R0) gastric cancer resection.
Journal Article
Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Carlos Miret,José Font,Rafael Molina,Mario García-Carrasco,Xavier Filella,M Ramos,Ricard Cervera,Antonio M. Ballesta,Miguel Ingelmo +8 more
TL;DR: In this paper, the authors evaluated serum levels of sFas, bcl-2, IL-10 and alfa-TNF in human systemic lupus erythematosus (SLE) patients and analyzed their relationship with disease activity and with regulation of the apoptotic process.
Journal Article
CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
Rafael Molina,Xavier Filella,Jose M. Auge,Elvira Bosch,Aureli Torné,Jaume Pahisa,J.A. Lejarcegui,Angels Rovirosa,Begoña Mellado,Jaume Ordi,Albert Biete +10 more
TL;DR: SCC is the tumor marker of choice in squamous tumors and the addition of CEA or CYFRA 21.1 does not significantly increase the sensitivity obtained by using SCC alone, as indicated by Multivariate analysis.
Journal ArticleDOI
Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA.
Xavier Filella,Rafael Molina,J.M. Piqué,Juan Carlos García-Valdecasas,J.J. Grau,F. Novell,Emiliano Astudillo,A.d. de Lacy,M. Daniels,Antonio M. Ballesta +9 more
TL;DR: The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA and sensitivity in the early diagnosis of recurrence was much lower than that obtained for CEA.